基因定义的少突胶质细胞瘤在MRI上以肿瘤边界不清为特征
回顾性纳入148例成人WHO II-III级浸润性胶质瘤患者,评估1p/19q共缺失与MRI特征及ADC值的关联。90例(61%)为基因定义的少突胶质细胞瘤,其中92%边界不清,显著高于非共缺失肿瘤的45%(P<.0001);99%信号不均匀。较低的ADC均值可预测1p/19q共缺失(P=.0005)。
要点
- 基因定义的少突胶质细胞瘤92%(83/90)边界不清,显著高于非1p/19q共缺失肿瘤的45%(26/58)(P<.0001)。
- 基因定义的少突胶质细胞瘤99%(89/90)在T1和/或T2加权成像上信号不均匀。
- 在有ADC值的患者中,较低的ADC均值可预测1p/19q共缺失(P=.0005)。
核心结论
- WHO 2016基因定义的少突胶质细胞瘤影像特征与既往形态学定义的少突胶质细胞瘤不同,前者常边界不清且几乎总是信号不均匀。
研究设计与样本
- 回顾性研究,纳入148例成人未治疗WHO II-III级浸润性胶质瘤患者,均有组织学少突胶质细胞形态、已知1p/19q状态及至少1次术前MRI;评估1p/19q共缺失与肿瘤影像特征及ADC值的关联。
关键影像表现/征象
- 基因定义的少突胶质细胞瘤中83/90(92%)边界不清,非1p/19q共缺失肿瘤中26/58(45%)边界不清(P<.0001)。
- 基因定义的少突胶质细胞瘤中89/90(99%)在T1和/或T2加权成像上信号不均匀。
诊断标准与关键数值
- 1p/19q共缺失肿瘤90/148(61%)对应基因定义的少突胶质细胞瘤,无共缺失肿瘤58/148(39%)对应星形细胞肿瘤。
- 在有ADC值的患者中,较低的ADC均值可预测1p/19q共缺失(P=.0005)。
临床应用与阅片要点
- 阅片时注意基因定义的少突胶质细胞瘤常表现为边界不清,而非既往认为的边界清晰。
- 基因定义的少突胶质细胞瘤几乎总是T1和/或T2加权成像信号不均匀。
- 较低的ADC均值可能提示1p/19q共缺失。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: In 2016, the World Health Organization revised the brain tumor classification, making IDH mutation and 1p/19q codeletion the defining features of oligodendroglioma. To determine whether imaging characteristics previously associated with oligodendroglial tumors are still applicable, we evaluated the MR imaging features of genetically defined oligodendrogliomas.
MATERIALS AND METHODS: One hundred forty-eight adult patients with untreated World Health Organization grade II and III infiltrating gliomas with histologic oligodendroglial morphology, known 1p/19q status, and at least 1 preoperative MR imaging were retrospectively identified. The association of 1p/19q codeletion with tumor imaging characteristics and ADC values was evaluated.
RESULTS: Ninety of 148 (61%) patients had 1p/19q codeleted tumors, corresponding to genetically defined oligodendroglioma, and 58/148 (39%) did not show 1p/19q codeletion, corresponding to astrocytic tumors. Eighty-three of 90 (92%) genetically defined oligodendrogliomas had noncircumscribed borders, compared with 26/58 (45%) non-1p/19q codeleted tumors with at least partial histologic oligodendroglial morphology (P < .0001). Eighty-nine of 90 (99%) oligodendrogliomas were heterogeneous on T1- and/or T2-weighted imaging. In patients with available ADC values, a lower mean ADC value predicted 1p/19q codeletion (P = .0005).
CONCLUSIONS: Imaging characteristics of World Health Organization 2016 genetically defined oligodendrogliomas differ from the previously considered characteristics of morphologically defined oligodendrogliomas. We found that genetically defined oligodendrogliomas were commonly poorly circumscribed and were almost always heterogeneous in signal intensity.
引用
- Johnson DR, Diehn FE, Giannini C, et al. Genetically Defined Oligodendroglioma Is Characterized by Indistinct Tumor Borders at MRI. AJNR Am J Neuroradiol. 2017. PMID: 28126746. doi:10.3174/ajnr.A5070
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。